{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:55:33Z","timestamp":1791114933346,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.02.071","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T04:44:13Z","timestamp":1236141853000},"page":"2649-2652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication"],"prefix":"10.1016","volume":"27","author":[{"given":"Philip","family":"Minor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2009.02.071_bib1","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1086\/498171","article-title":"When can we stop using oral poliovirus vaccine?","volume":"192","author":"Hull","year":"2005","journal-title":"J Infect Dis"},{"issue":"1O","key":"10.1016\/j.vaccine.2009.02.071_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.47102\/annals-acadmedsg.V34N10p593","article-title":"Infectious disease eradication: poliomyelitis as a lesson in why \u201cclose\u201d is not good enough","volume":"34","author":"Ong","year":"2005","journal-title":"Ann Acad Med Singapore"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.071_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biologicals.2006.02.005","article-title":"Vaccine-derived poliovirus from long term excretors and the end game of polio eradication","volume":"34","author":"Martin","year":"2006","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.071_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/infdis\/168.5.1105","article-title":"Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine","volume":"168","author":"Abraham","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.071_bib5","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"issue":"1 1","key":"10.1016\/j.vaccine.2009.02.071_bib6","first-page":"917","article-title":"Vaccine-associated paralytic polio in India","volume":"80","author":"John","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"5566","key":"10.1016\/j.vaccine.2009.02.071_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.vaccine.2009.02.071_bib8","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1128\/JVI.77.15.8366-8377.2003","article-title":"Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.071_bib9","unstructured":"Paralytic poliomyelitis in Madagascar, 2002. Wkly Epidemiol Rec 2002;77(29):241\u20132."},{"key":"10.1016\/j.vaccine.2009.02.071_bib10","unstructured":"Acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines, 2001. MMWR Morb Mortal Wkly Rep 2001;50(40):874\u20135."},{"issue":"5","key":"10.1016\/j.vaccine.2009.02.071_bib11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/506359","article-title":"An outbreak of poliomyelitis caused by type I vaccine-derived poliovirus in China","volume":"194","author":"Liang","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.071_bib12","unstructured":"World Health Organization. Cessation of routine oral polio vaccine (OPV) use after global polio eradication: Framework for national policy makers in OPV-using countries. WHO\/POLIO\/05.02; 2005."},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.02.071_bib13","first-page":"33","article-title":"Emerging\/disappearing viruses future issues concerning polio eradication","volume":"82","author":"Minor","year":"2002","journal-title":"Virus Res"},{"issue":"9420","key":"10.1016\/j.vaccine.2009.02.071_bib14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","article-title":"Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man","volume":"363","author":"MacLennan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.02.071_bib15","unstructured":"Expanded Program on Immunization. Report of the meeting on the scientific basis for stopping polio immunization, Geneva, 23\u201325 March 1998. World Health Organization; 1998. WHO document WHO\/EPI\/GEN\/98.12."},{"issue":"9446","key":"10.1016\/j.vaccine.2009.02.071_bib16","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/S0140-6736(04)17351-0","article-title":"Two good reasons to drop type 2 virus from oral polio vaccine","volume":"364","author":"John","year":"2004","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.vaccine.2009.02.071_bib17","first-page":"E 020718","article-title":"Reported synthesis of poliovirus and implications for polio eradication and bioterrorism","volume":"7","author":"Hoile","year":"2002","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.vaccine.2009.02.071_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/adc.78.6.571","article-title":"Polio vaccine: is it time for a change?","volume":"78","author":"Finn","year":"1998","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.vaccine.2009.02.071_bib19","first-page":"47","article-title":"Polio control after certification: major issues outstanding","volume":"82","author":"Fine","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2009.02.071_bib20","article-title":"Poliomyelitis outbreaks in Africa and Asia: importation of infections a serious risk for polio-free countries with low vaccine coverage","volume":"11","author":"Hovi","year":"2006","journal-title":"Euro Surveill"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:55Z","timestamp":1759400155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":20,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003181"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}